BG61034B1 - Заместени 3-(пиридиниламино)-индоли и бензо(в)тиофени, метод за получаването им и приложението им като лекарствени средства - Google Patents

Заместени 3-(пиридиниламино)-индоли и бензо(в)тиофени, метод за получаването им и приложението им като лекарствени средства Download PDF

Info

Publication number
BG61034B1
BG61034B1 BG96202A BG9620292A BG61034B1 BG 61034 B1 BG61034 B1 BG 61034B1 BG 96202 A BG96202 A BG 96202A BG 9620292 A BG9620292 A BG 9620292A BG 61034 B1 BG61034 B1 BG 61034B1
Authority
BG
Bulgaria
Prior art keywords
compound
formula
lower alkyl
group
hydrogen
Prior art date
Application number
BG96202A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG96202A (bg
Inventor
Richard Effland
Joseph Klein
Lawrence Martin
Original Assignee
Hoechst Marion Roussel, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Inc. filed Critical Hoechst Marion Roussel, Inc.
Publication of BG96202A publication Critical patent/BG96202A/bg
Publication of BG61034B1 publication Critical patent/BG61034B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG96202A 1991-04-17 1992-04-09 Заместени 3-(пиридиниламино)-индоли и бензо(в)тиофени, метод за получаването им и приложението им като лекарствени средства BG61034B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (2)

Publication Number Publication Date
BG96202A BG96202A (bg) 1993-12-24
BG61034B1 true BG61034B1 (bg) 1996-09-30

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96202A BG61034B1 (bg) 1991-04-17 1992-04-09 Заместени 3-(пиридиниламино)-индоли и бензо(в)тиофени, метод за получаването им и приложението им като лекарствени средства

Country Status (25)

Country Link
US (1) US5177088A (zh)
EP (1) EP0509402B1 (zh)
JP (1) JP2617650B2 (zh)
KR (1) KR100254027B1 (zh)
AT (1) ATE161840T1 (zh)
AU (1) AU655253B2 (zh)
BG (1) BG61034B1 (zh)
CA (1) CA2066332C (zh)
CS (1) CS117192A3 (zh)
DE (1) DE69223837T2 (zh)
DK (1) DK0509402T3 (zh)
ES (1) ES2111580T3 (zh)
FI (1) FI105096B (zh)
GR (1) GR3026317T3 (zh)
HU (1) HU215113B (zh)
IE (1) IE921235A1 (zh)
IL (1) IL101599A (zh)
MX (1) MX9201759A (zh)
NO (1) NO180486C (zh)
NZ (1) NZ242359A (zh)
PL (1) PL168905B1 (zh)
RO (1) RO109847B1 (zh)
RU (1) RU2060254C1 (zh)
TW (1) TW200477B (zh)
ZA (1) ZA922807B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
PT833820E (pt) * 1995-06-06 2001-07-31 Aventis Pharmaceuticals Inc Av Derivados de benzisoxazol e indazol uteis como agentes antipsicoticos
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
AU720466B2 (en) * 1996-12-27 2000-06-01 Hoechst Marion Roussel, Inc. N-(pyridinylamino)isoindolines and related compounds
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
IL148622A0 (en) * 1999-09-14 2002-09-12 Aventis Pharm Prod Inc Benzisoxazolyl-pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as d4 antagonists
DE10029371A1 (de) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
WO2005118539A1 (en) 2004-06-01 2005-12-15 F.Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
DE602006009138D1 (de) 2005-11-30 2009-10-22 Hoffmann La Roche 3-amino-2-arylpropylazaindole und anwendungen davon
EP1960355A1 (en) 2005-11-30 2008-08-27 F.Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles and aza-substituted indoles
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
CN101952281B (zh) * 2008-01-04 2014-04-02 株式会社Lg生命科学 具有细胞、组织及器官保存效果的吲哚及吲唑衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049779B1 (en) * 1980-09-18 1984-10-31 Asahi Kasei Kogyo Kabushiki Kaisha 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
IE921235A1 (en) 1992-10-21
CA2066332C (en) 2003-07-29
AU1512192A (en) 1992-10-22
NO921505D0 (no) 1992-04-15
ZA922807B (en) 1992-11-25
ATE161840T1 (de) 1998-01-15
PL294239A1 (en) 1993-06-14
GR3026317T3 (en) 1998-06-30
HU9201297D0 (en) 1992-07-28
TW200477B (zh) 1993-02-21
CA2066332A1 (en) 1992-10-18
AU655253B2 (en) 1994-12-08
PL168905B1 (pl) 1996-05-31
NZ242359A (en) 1995-03-28
BG96202A (bg) 1993-12-24
RO109847B1 (ro) 1995-06-30
HUT62572A (en) 1993-05-28
DE69223837D1 (de) 1998-02-12
CS117192A3 (en) 1992-11-18
DK0509402T3 (da) 1998-09-07
MX9201759A (es) 1992-10-01
KR920019777A (ko) 1992-11-20
KR100254027B1 (ko) 2000-05-01
DE69223837T2 (de) 1998-06-25
US5177088A (en) 1993-01-05
NO180486C (no) 1997-04-30
RU2060254C1 (ru) 1996-05-20
ES2111580T3 (es) 1998-03-16
HU215113B (hu) 1998-12-28
FI105096B (fi) 2000-06-15
EP0509402A1 (en) 1992-10-21
JP2617650B2 (ja) 1997-06-04
EP0509402B1 (en) 1998-01-07
IL101599A (en) 1996-05-14
NO921505L (no) 1992-10-19
IL101599A0 (en) 1992-12-30
NO180486B (no) 1997-01-20
FI921693A (fi) 1992-10-18
FI921693A0 (fi) 1992-04-15
JPH05117266A (ja) 1993-05-14

Similar Documents

Publication Publication Date Title
BG61034B1 (bg) Заместени 3-(пиридиниламино)-индоли и бензо(в)тиофени, метод за получаването им и приложението им като лекарствени средства
JP3057109B2 (ja) 新規インドール誘導体
CZ111496A3 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n-n-disubstituted amino-3,4-dihydro-2h-1-benzopyranes
AU2008323526A1 (en) Indole compounds and methods for treating visceral pain
AU2003259158A1 (en) 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
NO326160B1 (no) N-(2-aryletyl)benzylaminer som antagonister av 5-HT6-reseptoren
JPH11506472A (ja) 5―ht1aおよび/または5―ht1d受容体の選択的(アンタ)アゴニストとしてのベンジル(イデン)―ラクタム誘導体、その調製法及びその使用法
JPH07504429A (ja) 5HT↓1cアンタゴニストとしてのインドール誘導体
SK382004A3 (en) 5-halo-tryptamine derivatives used as ligands of the 5-HT6 and/or 5-HT7 serotonin receptors
EP1242076A1 (en) 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
JP2003524571A (ja) インドール−及び2,3−ジヒドロインドール誘導体、その製造方法及びその使用方法
JP2003521443A (ja) 4,5,6及び7−インドール及びインドリン誘導体、その製造方法及びその使用方法
MXPA01005905A (es) Ligandos selectivos de receptores de 5-ht6.
JP2007500164A (ja) インドール−6スルホンアミド誘導体、その調製及び5−ht−6モジュレータとしてのその使用
EP1749001B1 (en) 3-piperidinylisochroman-5-ols as dopamine agonists
JP2007500168A (ja) 1−スルホニルインドール誘導体、それらの調製及び5−ht6リガンドとしてのそれらの使用
US5328920A (en) Substituted (pyridinylamino)-indoles
Vangveravong et al. Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626
US6342498B1 (en) Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Dα antagonists
US6022880A (en) Substituted pyridylamino indoles
JP2009545555A (ja) 置換インダニルスルホンアミド化合物、それらの調製、および薬剤としての使用
JPH09512025A (ja) 5ht▲下2c▼および5ht▲下2b▼アンタゴニストとしての三環式誘導体
Imanishi et al. New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation
CA2327513A1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
JP2001520641A (ja) 3−アリール−2−(1−置換−4−ピペリジニル)−1(1−ジ)オキソ−3h−ベンゾ〔d〕−イソチアゾール誘導体、その製造および神経伝達物質機能のモジュレーターとしてのその使用